Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Assets Average: 2023-2025

Historic Assets Average for InMed Pharmaceuticals (INM) over the last 3 years, with Jun 2025 value amounting to $13.7 million.

  • InMed Pharmaceuticals' Assets Average rose 29.85% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year increase of 29.85%. This contributed to the annual value of $13.7 million for FY2025, which is 5.68% up from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Assets Average of $13.7 million as of FY2025, which was up 5.68% from $13.0 million recorded in FY2024.
  • Over the past 5 years, InMed Pharmaceuticals' Assets Average peaked at $13.7 million during FY2025, and registered a low of $13.0 million during FY2024.
  • Moreover, its 3-year median value for Assets Average was $13.4 million (2023), whereas its average is $13.4 million.
  • Per our database at Business Quant, InMed Pharmaceuticals' Assets Average dropped by 3.59% in 2024 and then increased by 5.68% in 2025.
  • MRY analysis of 3 years shows InMed Pharmaceuticals' Assets Average stood at $13.4 million in 2023, then dropped by 3.59% to $13.0 million in 2024, then grew by 5.68% to $13.7 million in 2025.
  • Its Assets Average stands at $13.7 million for FY2025, versus $13.0 million for FY2024 and $13.4 million for FY2023.